How the case counting window affected vaccine efficacy calculations in randomized trials of COVID‐19 vaccines
Journal of Evaluation in Clinical Practice · 2024
DOI: 10.1111/jep.13900 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Evaluation in Clinical Practice, 2024. Verfasst von Peter Doshi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Practice, Sciences, and Health Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
- Numbersense, Inc, New York, New York, USA.
ORCID-Profile: Peter Doshi
Zitieren
APA
Doshi, P., & Fung, K. (2024). How the case counting window affected vaccine efficacy calculations in randomized trials of COVID‐19 vaccines. Journal of Evaluation in Clinical Practice. https://doi.org/10.1111/jep.13900
Vancouver
Doshi P, Fung K. How the case counting window affected vaccine efficacy calculations in randomized trials of COVID‐19 vaccines. Journal of Evaluation in Clinical Practice. 2024. doi:10.1111/jep.13900
BibTeX
@article{Doshi2024,
author = {Doshi, Peter and Fung, Kaiser},
title = {How the case counting window affected vaccine efficacy calculations in randomized trials of COVID‐19 vaccines},
journal = {Journal of Evaluation in Clinical Practice},
year = {2024},
doi = {10.1111/jep.13900}
}
EUVIMED